Case ReportPublished 12 October 2026Case Report: Longitudinal evaluation of cerebrospinal fluid Alzheimer’s disease core biomarkers in a case of refractory late-onset epilepsy of unknown etiologyTakafumi Wada · Akira Kuzuya · Kazuma Koda · Sakiho Ueda · Atsushi Shima · Nobukatsu Sawamoto · Akio Ikeda · Ryosuke Takahashi · Riki MatsumotoFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1807027
Mini ReviewPublished 9 October 2026Molecular mechanisms underpinning cognitive reserve and resilienceAmber Chen · Sreenithi Bhuvaneshwaran · Yash Akkara · Thomas Burke · Robert Perneczky · Magdalena SastreFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1957901
Original ResearchPublished 9 October 2026TSC1-mTORC1 signaling in Alzheimer’s disease: an integrated bioinformatic analysis linking gene expression to neuropathologyZheng Liu · Yuchen Yu · Yu Wang · Shuohan Ning · Tongshuai Huang · Jingqi Li · Sihan Fan · Chaolong LuFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1920487
ReviewPublished 8 October 2026Noninvasive diagnosis of Alzheimer’s disease: a review of emerging biomarkers and multimodal approachesJunsheng Zhao · Chenqi Nie · Rong Gao · Zekai Hu · Yajie LinFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1964029
Original ResearchPublished 6 October 2026Reduced serum LEFTY2 and disease-dependent biomarker associations in Alzheimer’s disease: an exploratory studyWei Wuli · Raymond Y. Lo · Horng-Jyh Harn · Tzyy-Wen Chiou · Yue-Xuan Xu · Yuncin Luo · Ivan Wijaya · Shinn-Zong LinFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1955495
ReviewPublished 2 October 2026Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectivesJun Kang · Yongbo Duan · Jiaxuan Bi · Jiangping Liu · Wenjun YanFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1952923
PerspectivePublished 2 October 2026Hydrogen gas and olfactory dysfunction in Alzheimer’s disease: the Hydrogen–Olfactory–Limbic hypothesisLigao Bao · Dunfu EerFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1937419
Original ResearchPublished 1 October 2026Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 ChristchurchCarlye Frisch · Lauren Baker · Gayathri Srinivasan · Albert E. Mintah · Salma Leyasi · Morgan Pedroza · Brooke Galyon · David A. BrafmanFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1856154
ReviewPublished 15 September 2026Mitohormesis linking metabolic dysfunction and neurodegeneration: implications for dementia and therapeutic strategiesToshiki Otoda · Hideto Nakajima · Tadateru TakayamaFrontiers in Molecular Neurosciencedoi 10.3389/fnmol.2026.1892506
ReviewPublished 20 August 2026Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targetsLianjing Xu · Ying Zhang · Li Jiang · Jin Feng Xing · Jing Hu · Tianye Lan · Guang TaFrontiers in Cellular Neurosciencedoi 10.3389/fncel.2026.1902577
ReviewPublished 10 June 2026Zinc-binding proteins in Alzheimer’s disease: mechanisms, therapeutic potential, and natural compound interventionsRiddhi Upadhyay · Susmita Kar · Murugan SevananFrontiers in Chemical Biologydoi 10.3389/fchbi.2026.1836070
ReviewPublished 2 January 2026Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterationsPinky · Zitin Wali · Neha · Prachi Tiwari · Mohamed El-Tanani · Syed Arman Rabbani · Suhel ParvezFrontiers in Synaptic Neurosciencedoi 10.3389/fnsyn.2025.1676317
